Evidence map›Paper›PMID 31275456›Full record

ArticleDisease markers2019

Associations of

Qifei Wang, Chong Tang, Junxiu Jia, Guangwu Zhang, Zheng Liu

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pharmacogenomics and personalized medicine · 2021
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Qifei WangDepartment of Orthopedics, Peking University Shougang Hospital, Shijingshan District, Beijing, China.ORCID 0000-0002-0863-7730
Chong TangDepartment of Orthopedics, Peking University Shougang Hospital, Shijingshan District, Beijing, China.
Junxiu JiaDepartment of Orthopedics, Peking University Shougang Hospital, Shijingshan District, Beijing, China.ORCID 0000-0001-8936-3024
Guangwu ZhangDepartment of Orthopedics, Peking University Shougang Hospital, Shijingshan District, Beijing, China.
Zheng LiuDepartment of Orthopedics, Peking University Shougang Hospital, Shijingshan District, Beijing, China.ORCID 0000-0003-2522-074X
Peking University Shougang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOsteoporosis (OP) is a common polygenic disorder in the aging population, and several single nucleotide polymorphisms (SNPs) in the alpha-L-iduronidase ( MATERIALS AND

methodsA cohort of 328 unrelated senile osteoporosis (SOP) patients with or without osteoporotic fractures was recruited. rs3755955, rs6831280, and rs28377268 polymorphisms were identified using SNaPshot technology. BTM levels were determined by electrochemiluminescence (ECL). Bone mineral densities (BMDs) at the lumbar spine (LS) and proximal femur sites were measured by dual-energy X-ray absorptiometry (DEXA) in all subjects. The Hardy-Weinberg equilibrium (HWE) test was performed. HWE

resultsThe chi-square test indicated that genotype distributions in the control group conformed to HWE (

conclusions

Indexed as

Polymorphism, Single NucleotideAgedAged, 80 and overBone DensityChinaFemaleHumansIduronidaseMaleOsteoporotic FracturesPatched-1 ReceptorIDUA protein, humanIduronidasePatched-1 ReceptorPTCH1 protein, human

Identifiers

PMID31275456
PMCPMC6589188
OpenAlexW2947461647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.